|
Overview | Product information | Accredo services | Contact team
Nutropin AQ is a liquid formulation that is administered with a syringe or in a cartridge formulation administered with its corresponding Nutropin AQ Pen® device.
Approved for the following diagnoses:
- Growth hormone deficiency (GHD) in children and adults
- Growth failure associated with chronic renal insufficiency (CRI) prior to kidney transplantation
- Short stature associated with Turner syndrome
- Idiopathic short stature
For more information on Nutropin AQ, please visit NutropinAQ.com or download the full prescribing information.
Nutropin AQ and Nutropin AQ Pen are registered trademarks of Genentech, Inc.
|